The combination of different antiphospholipid antibody subgroups in the sera of patients with autoimmune diseases is a strong predictor for thrombosis

Immunobiology

Volumn 207, Issue 1, 2003, Pages 65-71

  von Landenberg, Philipp ^a   Schölmerich, Jürgen ^a   von Kempis, Johannes ^b   Lackner, Karl J ^c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CROHN DISEASE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MIXED CONNECTIVE TISSUE DISEASE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCLERODERMA; SERODIAGNOSIS; SEROPREVALENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; WEGENER GRANULOMATOSIS;

EID: 0037216699     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0171-2985(04)70166-7     Document Type: Article

References (33)

1. Harris, E. N., A. E. Gharavi, M. L. Boey, B. M. Patel, C. G. Mackworth-Young, S. Loizou, and G. R. Hughes. 1983. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2: 211-214.
2. Alarcon-Segovia, D., and J. Sanchez-Guerrero. 1989. Primary antiphospholipid syndrome. J. Rheumatol. 16: 482-488.
3. Sammaritano, L. R., A. E. Gharavi, and M.D. Lockshin. 1990. Antiphospholipid antibody syndrome: immunologic and clinical aspects. Semin. Arthritis Rheum. 20: 81-96.
4. Asherson, R. A., M. A. Khamashta, J. Ordi-Ros, R. H. Derksen, S. J. Machin, J. Barquinero, H. H. Outt, E. N. Harri, M. Vilardell-Torres, and G. R. Hughes. 1989. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 68: 366-374
5. von Muhlen, C. A., and E. M. Tan. 1995. Auto-antibodies in the diagnosis of systemic rheumatic diseases. Semin. Arthritis Rheum. 24: 323-358.
6. Komatireddy, G. R., G. S. Wang, G. C. Sharp, and R. W. Hoffman. 1997. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease. J. Rheumatol. 24: 319-322
7. Picillo, U., S. Migliaresi, M. R. Marcialis, A. M. Ferruzzi, and G. Tirri. 1997. Clinical setting of patients with systemic sclerosis by serum autoantibodies. Clin. Rheumatol. 16: 378-383
8. Chiarantini, E., R. Valanzano, A. A. Liotta, A. P. Cellai, S. Fedi, I. Ilari, D. Prisco, F. Tonelli, and R. Abbate. 1996. Hemostatic abnormalities in inflammatory bowel disease. Thromb. Res. 82: 137-146.
9. Mevorach, D., Y. Goldberg, J. M. Gomori, and D. Rachmilewitz. 1996. Antiphospholipid syndrome manifested by ischemic stroke in a patient with Crohn's disease. J. Clin. Gastroenterol. 22: 141-143.
10. Souto, J. C., M. Borrell, J. Fontcuberta, and M. Roca. 1995. Antiphospholipid antibodies in inflammatory bowel disease. Dig. Dis. Sci. 40: 1524-1525.
11. Vianna, J. L., D. P. D'Cruz, M. A. Khamashta, R. A. Asherson, and G. R. Hughes. 1992. Anticardiolipin antibodies in a patient with Crohn's disease and thrombosis. Clin. Exp. Rheumatol. 10: 165-168.
12. Kobayashi, T., E. Stang, K. S. Fang, P. de Moerloose, R. G. Parton, and J. Gruenberg. 1998. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature. 392: 193-197.
13. Hughes, G. R. 1998. Hughes' syndrome: the antiphospholipid syndrome. A historical view. Lupus. 7: 1-4.
14. Blank, M., A. Tincani, AND Y. Shoenfeld. 1994. Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies. J. Rheumatol. 21: 100-104
15. Pierangeli, S. S., J. H. Barker, D. Stikovac, D. Ackerman, G. Anderson, J. Barquinero, R. Acland, and E. N. Harris. 1994. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb. Haemost. 71: 670-674.
16. Palosuo, T., J. Virtamo, J. Haukka, P. R. Taylor, K. Aho, M. Puurunen, and O. Vaarala. 1997. High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men - a nested case-control study. Thromb. Haemost. 78: 1178-1182.
17. Cuadrado, M. J., F. Tinahones, M. T. Camps, E. de Ramon, J. M. Gomez-Zumaquero, F. Mujic, M. A. Khamashta, and G. R. Hughes. 1998. Antiphospholipid, anti-beta 2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome. QJM 91: 619-626
18. Lopez-Soto, A., R. Cervera, J. Font, A. Bove, J. C. Reverter, F. J. Munoz, C. Miret, G. Espinosa, A. Ordinas, and M. Ingelmo. 1997. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients. Clin. Exp. Rheumatol. 15: 143-149.
19. Perez-Vazquez, M. E., A. R. Villa, C. Drenkard, J. Cabiedes, and D. Alarcon-Segovia. 1993. Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classicategory of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus. J. Rheumatol. 20: 437-442.
20. Finazzi, G., V. Brancaccio, M. Moia, N. Ciaverella, M. G. Mazzucconi, P. C. Schinco, M. Ruggeri, E. M. Pogliani, G. Gamba, E. Rossi, F. Baudo, C. Manotti, A. D'Angelo, G. Palareti, V. de Stefano, M. Berrettini, and T. Barbui. 1996. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am. J. Med. 100: 530-536.
21. Alarcon-Segovia, D., M. Mestanza, J. Cabiedes, and A. R. Cabral. 1997. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays. J. Rheumatol. 24: 1545-1551.
22. Munoz-Rodriguez, F. J., J. Font, R. Cervera, J. C. Reverter, D. Tassies, G. Espinosa, A. Lopez-Soto, F. Carmona, J. Balasch, A. Ordinas, and M. Ingelmo. 1999. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin. Arthritis Rheum. 29: 182-190
23. Toschi, V., A. Motta, C. Castelli, M. L. Paracchini, D. Zerbi, and A. Gibelli. 1998. High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause. Stroke 29: 1759-1764.
24. Out, H. J., M. van Vliet, P. G. de Groot PG, and R. H. Derksen. 1992. Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 51: 353-357.
25. Manfredi, A. A., P. Rovere, S. Heltai, G. Galati, N. Nebbia, A. Tincani, G. Balestrieri, and M. G. Sabbadini. 1998 Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein I. Arthritis Rheum. 41: 215-223.
26. Manfredi, A. A., P. Rovere, G. Galati, S. Heltai, E. Bozzolo, L. Soldini, J Davoust, G. Balestrieri, A. Tincani, and M. G. Sabbadini. 1998 Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies. Arthritis Rheum. 41: 205-214.
27. McCluskey, J., A. D. Farris, C. L. Keech, A. W. Purcell, M. Rischmueller, G. Kinoshita, P. Reynolds, and T. P. Gordon. 1998. Determinant spreading: lessons from animal models and human disease. Immunol. Rev. 164: 209-229.
28. Bevers, E. M., P. Comfurius, D. W. Dekkers, and R. F. Zwaal. 1999. Lipid translocation across the plasma membrane of mammalian cells. Biochim. Biophys. Acta 1439: 317-330.
29. Silvestris, F., M. A. Frassanito, P. Cafforio, D. Potenza, M. di Loreto, M. Tucci, M. A. Grizzuti, B. Nico, and F. Dammacco. 1996. Antiphosphatidylserine antibodies in human immunodeficiency virus-1 patients with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxicity. Blood 87: 5185-5195
30. Mevorach, D., J. L. Zhou, X. Song, and K. B. ElKon. 1998. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med. 188: 387-392
31. Hochberg; M. C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40: 1725.
32. Yodfat, O., M. Blank, I. Krause, and Y. Shoenfeld. 1996. The pathogenic role of anti-phosphatidylserine antibodies: active immunization with the antibodies leads to the induction of antiphospholipid syndrome. Clin. Immunol. Immunopathol. 78: 14-20.
33. Blank, M., I. Krause, M. Fridkin, N. Keller, J. Kopolovic, I. Goldberg, A. Tobar, and Y. Shoenfeld. 2002. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J. Clin. Invest. 109: 797-804.